Home » Archive

Marketwire, News, Syndication »

Quidel Receives CE Mark for Its Molecular Diagnostic Test for Human Metapneumovirus (hMPV)

Posted by Mary Canady September 21st, 2011 .
No Comments

SAN DIEGO, CA–(Marketwire – Sep 21, 2011) – Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cell-based virology assays, announced today that it has received the CE Mark for the Quidel® Molecular hMPV…

More...

Marketwire, News, Syndication »

Quidel Receives CE Mark for Its Molecular Diagnostic Test for Human Metapneumovirus (hMPV)

Posted by Mary Canady September 21st, 2011 .
No Comments

SAN DIEGO, CA–(Marketwire – Sep 21, 2011) – Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cell-based virology assays, announced today that it has received the CE Mark for the Quidel® Molecular hMPV…

More...

Uncategorized »

True Diagnostics Receives sFDA Clearance for Its TrueDX(TM) Platform With TSH

Posted by Mary Canady September 20th, 2011 .
No Comments

SAN DIEGO, CA–(Marketwire – Sep 20, 2011) – True Diagnostics, Inc.T (www.TrueDiagnostics.com) announces the Company has received sFDA clearance for its TrueDXT Platform with its first test for TSH and expects shipments to China to begin before the e…

More...

Marketwire, News, Syndication »

True Diagnostics Receives sFDA Clearance for Its TrueDX(TM) Platform With TSH

Posted by Mary Canady September 20th, 2011 .
No Comments

SAN DIEGO, CA–(Marketwire – Sep 20, 2011) – True Diagnostics, Inc.T (www.TrueDiagnostics.com) announces the Company has received sFDA clearance for its TrueDXT Platform with its first test for TSH and expects shipments to China to begin before the e…

More...

Marketwire, News, Syndication »

Medistem to Present Patient Safety Data on Endometrial Regenerative Cell Product for Treatment of Heart Failure

Posted by Mary Canady September 19th, 2011 .
No Comments

SAN DIEGO, CA–(Marketwire – Sep 19, 2011) – Medistem Inc. (PINKSHEETS: MEDS) announced it will be presenting results from cardiac patients treated with the company’s Endometrial Regenerative Cell (ERC) universal donor stem cell product at the upcomi…

More...

Marketwire, News, Syndication »

Cytori Amends and Expands Credit Facility Led by GE Capital, Healthcare Financial Services

Posted by Mary Canady September 12th, 2011 .
No Comments

SAN DIEGO, CA–(Marketwire – Sep 12, 2011) – Cytori Therapeutics (NASDAQ: CYTX) amended its loan facility with GE Capital, Healthcare Financial Services, Oxford Finance Corporation and Silicon Valley Bank by extending the maturity date from June 201…

More...

Uncategorized »

Cytori Amends and Expands Credit Facility Led by GE Capital, Healthcare Financial Services

Posted by Mary Canady September 12th, 2011 .
No Comments

SAN DIEGO, CA–(Marketwire – Sep 12, 2011) – Cytori Therapeutics (NASDAQ: CYTX) amended its loan facility with GE Capital, Healthcare Financial Services, Oxford Finance Corporation and Silicon Valley Bank by extending the maturity date from June 201…

More...

Marketwire, News, Syndication »

Medistem Submits Response to FDA Clinical Hold

Posted by Mary Canady August 26th, 2011 .
No Comments

SAN DIEGO, CA–(Marketwire – Aug 26, 2011) – Medistem Inc. (PINKSHEETS: MEDS) announced today filing with the FDA a response to clinical hold regarding the company’s FDA Phase I clinical trial application, BB-IND 13898, entitled “Allogeneic-Unrelate…

More...

Diagnostics, Headline, SDBN Blog, SDBN Events »

SDBN August 16th 2011 Event Featuring Pathway Genomics

Posted by Mary Canady July 29th, 2011 .
No Comments

We polled you late last year about events you’d like us to have in 2011, and diagnostics was one of the top items on the list. In San Diego, we have a great atmosphere for ‘growing’ diagnostics companies, because we have several world class medical and research facilities as well as biotech companies pushing the envelope in several molecular technologies. Pathway Genomics is a great local company focused on genetic testing for disease risk factors and personal wellness. Tests are ordered by individuals through their doctors to help improve treatment …

More...

Drug Discovery, Headline, SDBN Blog, SDBN Events, Uncategorized »

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

Posted by Mary Canady July 1st, 2011 .
No Comments

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug companies are hungry for drug candidates to fill their pipelines. Additionally, the abundance of drug discovery contract research organizations (CROs), the ability to manage them remotely, and the ability to find partners and tools more easily on the internet presents an interesting opportunity.
Our July 19th event is our first in a series of Virtual Biotech …

More...